Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/51883
Type
ArticleCopyright
Open access
Collections
- INI - Artigos de Periódicos [3645]
Metadata
Show full item record
RECENT ADVANCES IN CRYPTOCOCCUS AND CRYPTOCOCCOSIS
Affilliation
Universidad del Rosario. School of Medicine and Health Sciences. Translational Microbiology and Emerging Diseases (MICROS) Research Group. Bogota, Colombia.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Micologia. Rio de Janeiro, RJ, Brasil.
University of Sydney. Westmead Clinical School. Sydney Medical School. Sydney Institute for Infectious Diseases. Faculty of Medicine and Health. Westmead Hospital-Research and Education Network, Westmead Institute for Medical Research, , Molecular Mycology Research Laboratory. Centre for Infectious Diseases and Microbiology. Sydney, Australia / Curtin University. Curtin Medical School. Bentley, Australia.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Micologia. Rio de Janeiro, RJ, Brasil.
University of Sydney. Westmead Clinical School. Sydney Medical School. Sydney Institute for Infectious Diseases. Faculty of Medicine and Health. Westmead Hospital-Research and Education Network, Westmead Institute for Medical Research, , Molecular Mycology Research Laboratory. Centre for Infectious Diseases and Microbiology. Sydney, Australia / Curtin University. Curtin Medical School. Bentley, Australia.
Abstract
The members of the Cryptococcus neoformans and Cryptococcus gattii species complexes are the main etiological agents of cryptococcosis, a life-threatening fungal infection affecting mostly immunocompromised people, but also immunocompetent hosts or those with unrecognized risk factors.
Share